Application

19333264 · Stabilized Formulations Containing Anti-Interleukin-4 Receptor (IL-4R) Antibodies

Filed 2025-09-18 · Pending The official file ↗ · Art unit 1674 · Examiner Ruixiang Li Typical · CPC A61K 39/395 · Regeneron Pharmaceuticals, Inc. · Schwabe W&W, PC / Regeneron Pharmaceuticals, Inc.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

2.0 mo

to disposition n/a

Statutes raised

103

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in